Skip to main content

Bioharvest Sciences Inc.

BHST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723464

No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Bioharvest Sciences Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of BHST: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders922+13
Shares258.9K1.63M+1.37M (+531.0%)
Value$2.44M$8.48M+$6.04M (+247.7%)

New holders (14)

Institutions that held Bioharvest Sciences Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to BHST in Q4 2025
InstitutionSharesValue% of portfolio
Alyeska Investment Group, L.P.757,064$3.93M0.01%
Thompson Siegel & Walmsley LLC374,717$1.95M0.03%
Evercore Wealth Management, LLC139,470$723.8K0.01%
King Luther Capital Management Corp40,000$207.6K0.00%
XTX Topco Ltd33,275$172.7K0.00%
Jane Street Group, LLC27,998$145.3K0.00%
Quadrature Capital Ltd27,065$140.5K0.00%
Marshall Wace, LLP21,235$110.2K0.00%
Citadel Advisors LLC15,367$79.8K0.00%
Susquehanna International Group, LLP14,737$76.5K0.00%
HRT Financial LP14,632$75.0K0.00%
Geode Capital Management, LLC11,811$61.3K0.00%
Virtu Financial LLC11,556$60.0K0.00%
UBS Group AG1,173$6.09K0.00%

Sold out (1)

Institutions that held Bioharvest Sciences Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of BHST in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
LPL Financial LLC20,000$188.2K